ATG5型
自噬
淋巴瘤
套细胞淋巴瘤
癌症研究
抗药性
细胞培养
细胞凋亡
化学
病毒学
医学
生物
免疫学
微生物学
生物化学
遗传学
作者
Shunhua Zhou,Li Zhang,Xiaoming Li,Junling Tang
出处
期刊:Zhongguo shi yan xue ye xue za zhi
日期:2021-04-01
卷期号:29 (2): 500-507
标识
DOI:10.19746/j.cnki.issn.1009-2137.2021.02.030
摘要
Objective To investigate the effect of autophagy on the drug resistance of different human lymphoma cells. Methods Human Burkitt's lymphoma cell Daudi, human B lymphoma cell SUDHL-4, and human mantle cell lymphoma cell JeKo-1 were taken as the research subjects. The expression of Atg5 was inhibited by the treatments of autophagy inhibitors or stable interference via lentivirus infection. The autophagy activity of B lymphoma cell was changed, and the changes of lymphoma cells to the drug resistance of ADR and VCR was observed. Results JeKo-1 cells showed the strongest resistance to ADR and VCR, followed by SUDHL-4, and Daudi cells showed the weakest resistance to ADR and VCR. At the same time, JeKo-1 cells showed the strongest autophagy activity, followed by SUDHL-4, and Daudi cells showed the weakest autophagy activity. After the treatments of autophagy inhibitors or stable Atg5 interference, the resistance of lymphoma cells to ADR and VCR was significantly weakened, and there was the positive correlation at the drug resistance and the autophagy activity of B lymphoma cell. Conclusion The higher autophagy activity in lymphoma cells, the lower chemotherapy resistance of the lymphoma cells after autophagy was inhibited.
科研通智能强力驱动
Strongly Powered by AbleSci AI